SLU-PP-332 10 mg – Synthetic ERR Agonist Research Compound

SLU-PP-332 is a novel synthetic small molecule currently being investigated for its effects on cellular energy metabolism, mitochondrial function, and endurance-related molecular pathways. Unlike peptide-based research compounds, SLU-PP-332 is a non-peptide small molecule that functions as a pan-estrogen-related receptor (ERR) agonist with activity at ERRα, ERRβ, and ERRγ, demonstrating the highest potency toward ERRα.

Estrogen-related receptors are nuclear receptors that regulate many genes involved in mitochondrial activity, oxidative phosphorylation, fatty acid utilization, and overall energy homeostasis. Because these pathways are heavily involved in physiological adaptations to aerobic exercise, SLU-PP-332 has attracted significant scientific interest as a chemical tool for studying exercise-associated metabolic signaling.

Mechanism of Action

SLU-PP-332 activates the ERR family of receptors, which influences transcriptional programs involved in:

• Mitochondrial biogenesis
• Cellular respiration
• Oxidative phosphorylation
• Fatty acid oxidation
• Skeletal muscle oxidative capacity
• Energy metabolism and endurance-related pathways

By activating these pathways, researchers use SLU-PP-332 to explore how ERR signaling influences cellular adaptations normally associated with increased aerobic activity and mitochondrial demand.

Research Literature

The first major publication describing SLU-PP-332, titled “Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity,” demonstrated that the compound activates all three ERR receptors with a preference for ERRα.

PubMed study:
https://pubmed.ncbi.nlm.nih.gov/36988910/

In preclinical research, SLU-PP-332 increased oxidative muscle fibers, enhanced mitochondrial respiration, and improved exercise endurance in animal models. These findings established SLU-PP-332 as an important research tool for investigating the biological pathways involved in exercise adaptation.

Additional research published in The Journal of Pharmacology and Experimental Therapeutics further investigated SLU-PP-332 in models of obesity and metabolic dysfunction.

PubMed study:
https://pubmed.ncbi.nlm.nih.gov/37739806/

Researchers observed increased energy expenditure, enhanced fatty acid oxidation, reductions in fat accumulation, and improvements in several metabolic markers in animal models. These findings have expanded scientific interest in ERR agonists as tools for studying metabolism, mitochondrial function, and energy regulation.

It is important to emphasize that current SLU-PP-332 research remains preclinical, and the compound has not been approved for human therapeutic use.

Important Product Handling Information

Important: This product is supplied as a lyophilized (freeze-dried) small molecule compound. Following reconstitution, SLU-PP-332 forms a suspension rather than a fully dissolved solution.

SLU-PP-332 has very limited water solubility and is commonly dissolved using solvents such as DMSO in laboratory settings. Because DMSO is not utilized in this formulation, the compound remains suspended after reconstitution rather than fully dissolving into the liquid.

Before each withdrawal, the vial should be gently shaken or agitated to evenly redistribute the suspended SLU-PP-332 particles and ensure a consistent suspension throughout the solution.

Due to the particulate nature of the reconstituted suspension, researchers may prefer using a larger gauge needle when withdrawing the material to help ensure consistent collection of the suspended particles.

Researchers should avoid vigorous shaking that may introduce unnecessary foaming or air bubbles. Gentle inversion or agitation is typically sufficient to achieve an even distribution of the suspended material.

Research Applications

SLU-PP-332 is currently being investigated as a laboratory tool in research areas involving:

• Mitochondrial function and cellular energy production
• Exercise-associated molecular pathways
• Skeletal muscle metabolism
• Fatty acid oxidation
• Metabolic syndrome and obesity models
• Age-related changes in mitochondrial biology

As research into estrogen-related receptor signaling continues to expand, SLU-PP-332 remains an important small molecule for exploring the relationship between mitochondrial adaptation, energy metabolism, and exercise-related cellular responses.

For Research Use Only. Not for human or veterinary use.